# Urinary Tract Infections and Bacterial Multidrug Resistance in Kidney Transplant Impact on Function and Graft Survival

**Authors:** Hernán Javier Pájaro Huertas, María Viviana Pantoja Echeverri, Gustavo Aroca Martínez, Carlos Guido Musso, Alex Dominguez Vargaz, Henry J. González-Torres

PMC · DOI: 10.3390/clinpract15110215 · Clinics and Practice · 2025-11-19

## TL;DR

This study found that urinary tract infections in kidney transplant patients in Colombia are linked to antibiotic resistance and lower kidney function, but not to worse long-term graft survival.

## Contribution

The study provides new insights into the impact of UTIs and multidrug resistance on kidney transplant outcomes in a specific geographic region.

## Key findings

- UTIs were associated with significantly lower baseline and follow-up eGFR.
- Multidrug resistance was present in 66% of UTI-causing bacteria.
- UTIs were not found to increase the risk of graft loss.

## Abstract

Objective: This study aimed to evaluate the sociodemographic, clinical, paraclinical, and microbiological characteristics of kidney transplant recipients with and without urinary tract infection (UTI) and determine their impact on renal function and graft survival in a referral center in Atlántico, Colombia. Methods: We conducted a retrospective, observational, analytical study including 163 kidney transplant recipients between 2015 and 2020. Clinical and microbiological variables were compared according to UTI status. Renal function was assessed using estimated glomerular filtration rate (eGFR). Graft survival was analyzed with Kaplan–Meier curves, and predictors of graft loss were identified using Cox regression models. Results: UTI prevalence was 17.8% (29/163), with a higher proportion of women in the UTI (+) group compared to the UTI (−) group (62% vs. 34%, p = 0.004). Escherichia coli (59%) and Klebsiella spp. (31%) were the predominant pathogens, with MDR in 66% of isolates and carbapenem resistance in 28%. Patients with UTIs had significantly lower baseline and follow-up eGFR (p ≤ 0.002), yet five-year graft survival was comparable (93% vs. 91%, p = 0.54). Baseline eGFR (HR: 0.95, p < 0.001) and institutional referral (HR: 9.7, p = 0.010) were independent predictors of graft loss, whereas UTIs were not associated with increased risk. Conclusions: Post-transplant UTIs in Atlántico were characterized by high antimicrobial resistance and reduced renal function, but did not affect graft survival. Antimicrobial stewardship and institutional optimization strategies are essential to improve outcomes in this vulnerable population.

## Full-text entities

- **Diseases:** Bacterial (MESH:D001424), UTI (MESH:D014552)
- **Chemicals:** carbapenem (MESH:D015780)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12651641/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12651641/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12651641/full.md

---
Source: https://tomesphere.com/paper/PMC12651641